For the promise of personalized medicine to be realized, the health industry needs more people who can interpret genetic data and make that data meaningful to patients, according to a prominent Cleveland Clinic geneticist. The ability to tailor treatment to a patient’s genetic profile — plus, the rapidly declining cost of technology to analyze genetic […]
Cleveland Clinic geneticist Dr. Charis Eng is one of 65 new members elected to the Institutes of Medicine, a prestigious advisory group that serves as the health arm of the National Academy of Sciences.
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases
Charis Eng will advise the U.S. Department of Health and Human Services on the medical, ethical, legal and social implications of integrating genetic technologies into clinical and public health practice.